TG Therapeutics, Inc.
S&P 600
$53.89
-2.71%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.41.
- Comfortable interest cover: operating profit covers interest about 4.6 times.
- Return on equity is healthy at 74%.
- Net profit margin is strong at 72.6%.
- Current assets comfortably cover current liabilities (current ratio 4.1).
!Watch-points
- Return on capital employed is on the lower side at 8.3%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
12.65
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
4 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$8.25B
Current Price$ 53.89
High / Low$ 59.30 / 26.76
Stock P/E19.667883
Book Value$ 3.84
Dividend Yield0%
ROCE8.30%
ROE74.03%
Debt to Equity0.41
Current Ratio4.10
P/B Ratio13.099174
EPS$ 2.77
Debt$245.65M
PAT Margin72.56%
Cash PAT$447.24M
ICR4.61